A four-in-one pill cut blood pressure and cholesterol significantly in over-50s with no history of heart disease in a small British study, fueling debate about the use of a so-called polypill to ward off heart attacks and strokes. The idea of a “one-size-fits-all” cocktail of cheap generic heart drugs has been touted for 10 years, but its path to market remains unclear given regulatory hurdles and a lack of interest from big drugmakers focused on selling new patented medicines.
